SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 353 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $237,488 | -8.3% | 1,666 | -54.6% | 0.15% | -8.0% |
| Q1 2021 | $259,000 | -21.3% | 3,666 | 0.0% | 0.16% | -26.0% |
| Q4 2020 | $329,000 | -35.6% | 3,666 | 0.0% | 0.22% | -44.7% |
| Q3 2020 | $511,000 | -15.0% | 3,666 | 0.0% | 0.40% | -21.7% |
| Q2 2020 | $601,000 | +75.2% | 3,666 | 0.0% | 0.51% | +47.5% |
| Q1 2020 | $343,000 | -32.6% | 3,666 | -5.2% | 0.34% | +2.1% |
| Q4 2019 | $509,000 | +74.9% | 3,866 | 0.0% | 0.34% | +57.7% |
| Q3 2019 | $291,000 | +5.4% | 3,866 | +112.9% | 0.21% | +7.0% |
| Q2 2019 | $276,000 | +38.7% | 1,816 | +9.0% | 0.20% | +33.6% |
| Q1 2019 | $199,000 | +9.3% | 1,666 | 0.0% | 0.15% | -47.9% |
| Q4 2018 | $182,000 | -32.3% | 1,666 | 0.0% | 0.29% | +62.5% |
| Q3 2018 | $269,000 | +116.9% | 1,666 | -0.7% | 0.18% | +87.2% |
| Q2 2018 | $124,000 | – | 1,678 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Evolutionary Tree Capital Management, LLC | 68,937 | $5,138,000 | 3.04% |
| Avoro Capital Advisors LLC | 2,150,000 | $160,240,000 | 2.77% |
| Casdin Capital, LLC | 550,000 | $40,992,000 | 1.22% |
| TOBAM | 371,107 | $27,659,000 | 1.18% |
| Ikarian Capital, LLC | 455,900 | $33,978,000 | 1.14% |
| Eventide Asset Management | 697,156 | $51,959,000 | 0.77% |
| FOX RUN MANAGEMENT, L.L.C. | 4,902 | $365,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,500 | $2,348,000 | 0.62% |
| Sivik Global Healthcare LLC | 20,000 | $1,491,000 | 0.54% |
| Rock Springs Capital Management LP | 328,750 | $24,502,000 | 0.54% |